PACE Cancer Perception Index
We surveyed thousands of people in six countries to find out what they think about cancer treatment and care, the healthcare system, and patient involvement.
Learn MORE
Our Policy Network
The PACE Policy Network is made up of advocates, patients, scientists, and industry professionals, and is led by our Global Council. Its goal is to serve as a catalyst for cross-sector discussion and collaboration, and to improve public policies that determine the accessibility, speed, and value of progress against cancer.
While cancer is better understood today than ever before, there is much progress to make. PACE collaborates with patients, advocates, researchers, and our Global Council of oncology policy experts to encourage decisions that speed the development of new medicines and improve outcomes for cancer patients. We believe that through science, education, advocacy, and collaboration, we can build momentum that leads to real cures and new treatments for cancer, today... and tomorrow.
The Global Council
- Patrick Cobb, M.D. Public Policy Committee Chair Community Oncology Alliance
- Newton Crenshaw Vice President Lilly Oncology
- Nancy Davenport-Ennis Founder Patient Advocate Foundation
- Andrew C. von Eschenbach, M.D. President Samaritan Health Initiatives
- Richard B. Gaynor, MD Vice President Clinical Development and Medical Affairs, Lilly Oncology
- Clifford Goodman, Ph.D. Senior Vice President The Lewin Group
- Mike Hobday Director of Policy & Research Macmillan
- J. Gordon McVie, M.D. Senior Consultant European Institute of Oncology
- Sue Mahony, Ph.D. President Lilly Oncology
- Kathy Oliver Founding Co-Director International Brain Tumor Alliance
- Ken Paterson
- Tomas Philipson, Ph.D. Co-Founder Precision Heath Economics LLC
- Michael D. Peake, M.D. Consultant and Senior Lecturer Respiratory Medicine, University Hospitals of Leicester
- Bart Peterson Senior Vice President Corporate Affairs and Communications, Eli Lilly and Company
- Charles Turkelson, Ph.D. Senior Director of Research Center for Medical Technology Policy
The PACE Global Council brings together a small group of the world's most prominent oncology-policy thought leaders representing academia, industry, medicine, patient advocacy, and health-care assessment and payment.
Meet the CouncilOur Plan for Action
PACE is committed to encouraging public policies and health care decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. Here's our plan for moving forward.
Read More of Our Plan for Action
The Cancer Policy Environment
Barriers to Faster Oncology Innovation, and Strategies for Moving Forward
As a society, we still face many difficult barriers in the fight against cancer. This discussion paper is meant to provide a rough map of the cancer policy terrain and to encourage readers to focus on common challenges regardless of geography, culture, or profession.
Country Specific Initiatives
PACE is a global initiative that is currently active in the United States and Germany. We are launching soon in France, Italy, Japan, and the United Kingdom. Find out what we're working on in your country to learn how you can get involved.
Events
EAPM Conference on Innovation and Patient Access to Personalized Medicine
March 20-21, Dublin: PACE presented the results of the PACE Cancer Perception Index at the European Alliance for Personalized Medicine Conference, which explored the potential of personalized medicine in improving the health and wellbeing of individuals, as well as its integration into existing health systems.
see what's happeningWorking With Patient Advocacy
PACE believes that patients should be at the heart of all decisions affecting their treatment and care. While many can advocate for change, for better cancer care, it is really the patient 'voice' that has the most credibility and should have the greatest strength. In this respect, PACE is doing what it can to work with patient advocacy to understand their needs and the needs of those they represent; to find new ways of partnership working that enable the patient perspective to come to the fore.
Learn More